๐๏ธ Verified NIH Record โข Updated 2026-06-04
A Study of AL102 in Patients With Progressing Desmoid Tumors (NCT04871282)
RINGSIDE: A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients With Progressing Desmoid Tumors
๐ต Active, Not Recruiting Phase2 / Phase3 ๐ Investigational Drug / Biologic Sponsor: Immunome, Inc.
๐ฉบ Plain-English Summary (8th-Grade Level)
The current study is designed to evaluate the efficacy and safety of AL102 in patients with progressive desmoid tumors.
Who can join: Review the eligibility criteria below.
Location: Mayo Clinic โ Pheonix, Arizona
Age range: 12 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (53 Sites)
Showing the first 25 of 53 sites.
- Mayo Clinic โ Pheonix, Arizona
- City of Hope โ Duarte, California
- Sarcoma Oncology Research Center โ Santa Monica, California
- University of California at Los Angeles Hematology/Oncology โ Santa Monica, California
- Stanford University Medical Center โ Stanford, California
- Mayo Clinic โ Jacksonville, Florida
- NorthShore University Health System โ Evanston, Illinois
- Massachusetts General Hospital โ Boston, Massachusetts
- University of Michigan โ Ann Arbor, Michigan
- Jefferson City Medical Group โ Jefferson City, Missouri
- Washington University โ St Louis, Missouri
- Columbia University Irving Medical Center โ New York, New York
- Memorial Sloan Kettering Cancer Center โ New York, New York
- Levine Cancer Institute โ Charlotte, North Carolina
- Cleveland Clinic โ Cleveland, Ohio
- Ohio State University Wexner Medical Center โ Columbus, Ohio
- Oregon Health & Science University โ Portland, Oregon
- Jefferson University Hospital โ Philadelphia, Pennsylvania
- Fox Chase Cancer Center โ Philadelphia, Pennsylvania
- University of Pittsburgh Medical Center, Hillman Cancer Center โ Pittsburgh, Pennsylvania
- UTSW Simmons Cancer Center โ Dallas, Texas
- MD Anderson Cancer Center โ Houston, Texas
- Fred Hutchinson Cancer Center โ Seattle, Washington
- Chris O'Brien Lifehouse โ Camperdown, New South Wales
- Princess Alexandra Hospital โ Woolloongabba, Queensland
๐ Contact the Study Coordinator
Phone: (800) 664-4580
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
Explore by condition: All Desmoid clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.